期刊文献+

PET/T在肺部疾病中的应用价值 被引量:2

The clinical applications of the PET/CT in lung diseases
暂未订购
导出
摘要 目前,肺部疾病尤其是肺癌依然是威胁人类健康的主要疾病,早期准确地对该疾病的诊断、分期和再分期、治疗疗效评价等方面仍是临床的热点和难点问题。正电子发射型计算机断层显像(PET)/CT显像技术通过反映组织和病变的功能、代谢等分子水平上的变化,对肺部疾病的诊疗具有独特的优势和临床应用价值。本文通过复习相关文献及结合典型病例,对PET/CT在肺部疾病中的应用进行简要的概述。 At present, lung diseases, particularly lung cancer, remain the major diseases that threaten human health, and the diagnosis, staging and re-staging and therapy evaluation of lung diseases are still the hot and difficult problems. PET ( positron emission tomography) imaging can display the organie functions, metabolism, and other information at molecular level. PET has unique advantages and clinical application value in the diagnosis of lung diseases. This paper reviews the related litera- tures and presents typical cases for the discussion of PET/CT in lung diseases.
作者 李亚明
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第4期308-310,共3页 Chinese Journal of Practical Internal Medicine
关键词 体层摄影技术 发射型计算机 正电子 肺癌 positron emission tomography lung cancer
  • 相关文献

参考文献1

二级参考文献11

  • 1Flavio Crippa,Ettore Seregni,Roberto Agresti,Carlo Chiesa,Claudio Pascali,Anna Bogni,Donatella Decise,Vinicio De Sanctis,Marco Greco,Maria Grazia Daidone,Emilio Bombardieri.Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation[J].European Journal of Nuclear Medicine.1998(10)
  • 2Zhang DW,Zhang RG,Cheng GY.The surgical treatment of lung cancer: a retrospective analysis of 2004 cases[].Chinese Medical Journal.1999
  • 3Mountain.CF Revisions in the international system for staging lung cancer[].Chest.1997
  • 4Moldvay J,Scheid P,Wild P,et al.Predictive survival markers in patients with surgically resected non-small cell lung carcinoma[].Clinical Cancer Research.2000
  • 5Depierre,A,Milleron,B,Moro-Sibilot,D,Chevret,S,Quoix,E,Lebeau,B.French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1NO), II, and IIIa non-small-cell lung cancer[].Journal of Clinical Oncology.2002
  • 6Roth JA,,Atkinson EN,Fossella F,et al.Long-term followup of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stageⅢA non-small-cell lung cancer[].Lung Cancer.1998
  • 7Arriagada,R,Bergman,B,Dunant,A,Le,Chevalier,T,Pignon,JP,Vansteenkiste,J.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[].The New England Journal of Medicine.2004
  • 8Fischer JR,Lahm H.Validation of molecular and immunological factors with predictive importance in lung cancer[].Lung Cancer.2004
  • 9Pauwels,EK,Ribeiro,MJ,Stoot,JH,McCready,VR,Bourguignon,M,Maziere,B.FDG accumulation and tumor biology[].Nuclear Medicine and Biology.1998
  • 10Phelps ME.Positron emission tomography provides molecular imaging of biological processes[].Proceedings of the National Academy of Sciences of the United States of America.2000

共引文献16

同被引文献9

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部